Found 99 matching trials
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 PHASE1 The purpose of this study is to find the number of natural killer (NK) cell...
Show More Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Learn More & Join Trial
CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation PHASE1 The investigators propose a nonrandomized, Phase I study to assess the safe...
Show More Location
Hammersmith Hospital
Learn More & Join Trial
CIML NK Cell in Head & Neck Cancer PHASE1 This research study is evaluating the safety and efficacy of a combination ...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors PHASE1 This is a Phase 1 open-label, study designed to characterize the safety, to...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas PHASE1 Progress in the treatment of children with leukemia and lymphoma results in...
Show More Location
National University Hospital
Learn More & Join Trial
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020 PHASE1 Breast cancer is the second most common invasive malignancy and the leading...
Show More Learn More & Join Trial
Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML PHASE1 This phase 1/2 study is testing a new treatment for acute myeloid leukemia ...
Show More Location
Nationwide Children's Hospital
Learn More & Join Trial
Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia PHASE1 This is a phase I/II clinical trial using adoptive cell therapy with NK cel...
Show More Location
Hospital Universitario La Paz
Learn More & Join Trial
Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML) PHASE1 This is a single center, "modified standard design" dose escalation study d...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial